A negative screening of rare genetic variants in t... - BV FAPESP
Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

A negative screening of rare genetic variants in the ADIPOQ and STATH genes in cystic fibrosis

Full text
Author(s):
Coutinho, C. A. A. C. [1] ; Marson, F. A. L. [2, 1, 3] ; Ribeiro, J. D. [2] ; Bertuzzo, C. S. [1]
Total Authors: 4
Affiliation:
[1] Univ Estadual Campinas, Sch Med Sci, Dept Med Genet & Genom Med, POB 6111, BR-13081970 Campinas, SP - Brazil
[2] Univ Estadual Campinas, Sch Med Sci, Dept Pediat, POB 6111, BR-13081970 Campinas, SP - Brazil
[3] Sao Francisco Univ, Post Grad Program Hlth Sci, Ave Sao Francisco de Assis 218, BR-12916900 Braganca Paulista, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: PULMONOLOGY; v. 26, n. 3, p. 138-144, MAY-JUN 2020.
Web of Science Citations: 0
Abstract

Background: The phenotypic variability in cystic fibrosis (CF) is widely recognized and modulated by environmental and genetic factors, including CFTR pathogenic variants and modifier genes genetic variants. In this context, determining the presence of variants in genes involved in immune response may allow a better understanding of CF variability, mainly in lung disease. Thus, ADIPOQ and STATH genes were selected and the analysis of exons and exon/intron junctions was performed for the determination of variations in its sequence, to determine the possible genetic modulation. Methods: A total of 49 patients with CF, diagnosed for showing abnormal {[}chloride] levels in the sweat test, and identification of two pathogenic variants in CFTR categorized as class I and II were included. Genetic sequencing was performed for the identification of variants in the modifier genes. Results: In our analysis, there was absence of rare genetic variants in STATH and ADIPOQ genes associated with the clinical variability. Thus, we are not able to establish an association between the disease severity and rare genetic variants in STATH and ADIPOQ genes, considering exons and exon/intron junctions. Conclusions: Considering the negative screening for rare genetic variants in ADIPOQ and STATH genes, it may be concluded that these genes are not associated with phenotypic modulation of CF in our population. To understand the modifier genes and its action at CF variability it is essential to promote a better overview of the disease. Also, negative reports can help to direct new studies without the use of unnecessary financial support. (C) 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U. (AU)

FAPESP's process: 11/12939-4 - Association between polymorphisms in modifier genes in children and adolescent with allergic and non-allergic: mild, moderate and severe asthma
Grantee:Fernando Augusto de Lima Marson
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 15/12183-8 - Identification of prevalent mutations and clinical and functional characterization of children and adults with primary ciliary dyskinesia
Grantee:Jose Dirceu Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 11/18845-1 - Association between polymorphisms in modifier genes in children and adolescent with allergic and non-allergic mild, moderate and severe asthma
Grantee:Jose Dirceu Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 15/12858-5 - Identification of prevalent mutations and clinical and functional characterization of children and adults with primary ciliary dyskinesia
Grantee:Fernando Augusto de Lima Marson
Support Opportunities: Scholarships in Brazil - Post-Doctoral